Lipoprotein apheresis for lipoprotein(a) and cardiovascular disease

•Elevated Lp(a) is a CVD risk factor found in 30% of the population. •There is no available pharmacotherapy or lifestyle that reduces Lp(a) levels. •LA is the only effective therapy that significantly lowers Lp(a) and CVD risk. •Germany expanded LA access to include Lp(a) therapy and has shown CVD reduction. •One U.S. center treating 14 high Lp(a) patients with LA demonstrates CVD reduction. Background Elevated lipoprotein(a) [Lp(a)] is an...